ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.42 CNY | -0.67% |
|
-5.96% | -20.81% |
| Sales 2021 | 3.5B 484M | Sales 2022 | 4B 553M | Capitalization | 4.5B 622M |
|---|---|---|---|---|---|
| Net income 2021 | 115M 15.88M | Net income 2022 | 154M 21.27M | EV / Sales 2021 | 1.17 x |
| Net Debt 2021 | 364M 50.25M | Net Debt 2022 | 304M 41.92M | EV / Sales 2022 | 1.2 x |
| P/E ratio 2021 |
32.6
x | P/E ratio 2022 |
27.8
x | Employees | 4,654 |
| Yield 2021 |
0.83% | Yield 2022 |
0.74% | Free-Float | 64.81% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.67% | ||
| 1 week | -5.96% | ||
| Current month | -5.48% | ||
| 1 month | -7.25% | ||
| 3 months | -14.61% | ||
| 6 months | -25.87% | ||
| Current year | -20.81% |
1 week
7.03
7.89
1 month
7.038.13
Current year
5.969.60
1 year
5.9611.16
3 years
5.9616.98
5 years
5.5416.98
10 years
4.7619.99
| Managers | Title | Age | Since |
|---|---|---|---|
Tian Le Ru
CEO | Chief Executive Officer | 39 | 07-08-31 |
Jun Li
DFI | Director of Finance/CFO | 47 | 08-10-31 |
Yue E Hu
CHM | Chairman | 62 | 07-10-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Man He
CHM | Chairman | 52 | 08-03-17 |
Jun Zhang
BRD | Director/Board Member | 54 | 98-10-27 |
Wei Dong Zhu
BRD | Director/Board Member | 62 | 19-06-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 7.42 | -0.67% | 5 249 701 |
| 24-04-18 | 7.47 | -1.45% | 5,826,700 |
| 24-04-17 | 7.58 | +7.67% | 8,536,800 |
| 24-04-16 | 7.04 | -6.38% | 9,458,401 |
| 24-04-15 | 7.52 | -4.08% | 10,891,100 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, manufacture and distribution of biological medicines, chemical synthetic medicines and Chinese medicines. The Company's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The Company is also engaged in the retailing and wholesale of drugs. The Company conducts its businesses mainly in domestic markets, with Anhui province as its main market.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -20.81% | 343M | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- 000153 Stock
